Back to dashboard
CommercialCoverageMedium impact

Chromosomal Microarray Testing for the Evaluation of Pregnancy Loss (2.04.122)

Blue Shield of California·CA · OB-GYN, Genetics·Medical Policy
Effective date
Nov 1, 2025
We identified it
Nov 1, 2025
Days to comply
—

Summary

Blue Shield of California will cover chromosomal microarray testing for pregnancy loss evaluation starting November 1, 2025. Coverage applies to recurrent miscarriages (≥2 failed pregnancies) at ≤20 weeks gestation or any pregnancy loss after 20 weeks gestation.

Action Required

Action needed
Before November 1, 2025: Billing team must update Blue Shield of California coverage policies to include chromosomal microarray testing for pregnancy loss evaluation. Ensure proper documentation of pregnancy loss history (≥2 failed pregnancies for early loss or any loss after 20 weeks) to support medical necessity. Verify genetic counseling is provided and documented as recommended.

Related policy hubs